Pharma Mar, S.A. (FRA:PMRA)

Pharma Mar Statistics

Total Valuation

Pharma Mar has a market cap or net worth of EUR 1.26 billion. The enterprise value is 1.26 billion.

Market Cap	1.26B
Enterprise Value	1.26B

Important Dates

The last earnings date was Thursday, October 30, 2025.

Earnings Date	Oct 30, 2025
Ex-Dividend Date	Jun 25, 2025

Share Statistics

Current Share Class	17.21M
Shares Outstanding	n/a
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	12.04%
Owned by Institutions (%)	9.23%
Float	13.29M

Valuation Ratios

The trailing PE ratio is 37.10 and the forward PE ratio is 15.97.

PE Ratio	37.10
Forward PE	15.97
PS Ratio	7.04
PB Ratio	6.39
P/TBV Ratio	6.43
P/FCF Ratio	75.45
P/OCF Ratio	59.40
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 46.83, with an EV/FCF ratio of 75.48.

EV / Earnings	37.11
EV / Sales	7.04
EV / EBITDA	46.83
EV / EBIT	57.37
EV / FCF	75.48

Financial Position

The company has a current ratio of 2.73, with a Debt / Equity ratio of 0.25.

Current Ratio	2.73
Quick Ratio	0.94
Debt / Equity	0.25
Debt / EBITDA	1.87
Debt / FCF	3.01
Interest Coverage	4.34

Financial Efficiency

Return on equity (ROE) is 17.91% and return on invested capital (ROIC) is 5.69%.

Return on Equity (ROE)	17.91%
Return on Assets (ROA)	4.08%
Return on Invested Capital (ROIC)	5.69%
Return on Capital Employed (ROCE)	8.71%
Revenue Per Employee	358,552
Profits Per Employee	68,010
Employee Count	500
Asset Turnover	0.53
Inventory Turnover	0.19

Taxes

Income Tax	-9.09M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -1.27% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-1.27%
50-Day Moving Average	84.35
200-Day Moving Average	83.87
Relative Strength Index (RSI)	28.56
Average Volume (20 Days)	48

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Pharma Mar had revenue of EUR 179.28 million and earned 34.01 million in profits. Earnings per share was 1.95.

Revenue	179.28M
Gross Profit	169.48M
Operating Income	22.00M
Pretax Income	24.92M
Net Income	34.01M
EBITDA	26.95M
EBIT	22.00M
Earnings Per Share (EPS)	1.95

Balance Sheet

The company has 49.73 million in cash and 50.33 million in debt, giving a net cash position of -600,000.

Cash & Cash Equivalents	49.73M
Total Debt	50.33M
Net Cash	-600,000
Net Cash Per Share	n/a
Equity (Book Value)	197.51M
Book Value Per Share	11.33
Working Capital	153.95M

Cash Flow

In the last 12 months, operating cash flow was 21.24 million and capital expenditures -4.52 million, giving a free cash flow of 16.72 million.

Operating Cash Flow	21.24M
Capital Expenditures	-4.52M
Free Cash Flow	16.72M
FCF Per Share	n/a

Margins

Gross margin is 94.53%, with operating and profit margins of 12.27% and 18.97%.

Gross Margin	94.53%
Operating Margin	12.27%
Pretax Margin	13.90%
Profit Margin	18.97%
EBITDA Margin	15.03%
EBIT Margin	12.27%
FCF Margin	9.33%

Dividends & Yields

This stock pays an annual dividend of 0.80, which amounts to a dividend yield of 1.08%.

Dividend Per Share	0.80
Dividend Yield	1.08%
Dividend Growth (YoY)	23.08%
Years of Dividend Growth	1
Payout Ratio	41.02%
Buyback Yield	n/a
Shareholder Yield	1.08%
Earnings Yield	2.70%
FCF Yield	1.33%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on July 22, 2020. It was a reverse split with a ratio of 0.0833333333.

Last Split Date	Jul 22, 2020
Split Type	Reverse
Split Ratio	0.0833333333

Scores

Altman Z-Score	n/a
Piotroski F-Score	7